Antibiotics

It is a Benzoquinone antibiotic produced by the strain of Nocardia sp. M-53. It has activity against gram-positive bacteria and mycobacteria. In vivo, 6 mg/kg of Sakyomicin C had no effect against sarcoma 180A and leukemia P338 cells.

It is a Benzoquinone antibiotic produced by the strain of Nocardia sp. M-53. It has activity against gram-positive bacteria.

It is a peptide antibiotic produced by the strain of Samarospora sp. No. F-7762. It has anti-bacterial, yeast, fungi and protozoa effects, but the effect is not strong. The serum can reduce its activity.

Sangivamycin hydrochloride is a nucleoside (purine) antibiotic produced by the strain of Str. rimosus BA-90912. 0.02-0.05 μg/mL of Sangivamycin inhibits HeLa cells. It has weak inhibitory effect on sarcoma-180 and adenocarcinoma 755 in mice. It has obvious inhibitory effect on leukemia L-1210. When intraperitoneally administered, the drug binds to nucleic acids in tissues in mice through phosphorylation.

It is an aminoglycoside antibiotic produced by the strain of Str. sannanensis sp. nov. It has only weak antibacterial activity against a few bacteria.

It is an aminoglycoside antibiotic produced by the strain of Str. sannanensis sp. nov. It has weak antibacterial activity against Gram-positive bacteria.

It is an aminoglycoside antibiotic produced by the strain of Str. sannanensis sp. nov. It has weak antibacterial activity against Gram-positive bacteria.

It is an aminoglycoside antibiotic produced by the strain of Str. sannanensis sp. nov. It has weak antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.

It is an aminoglycoside antibiotic produced by the strain of Str. sannanensis sp. nov. It has only weak antibacterial activity against a few bacteria.

It is an aminoglycoside antibiotic produced by the strain of Str. sannanensis sp. nov. It has only weak antibacterial activity against a few bacteria.

It is an aminoglycoside antibiotic produced by the strain of Str. sannanensis sp. nov. It has weak antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.

It is an aminoglycoside antibiotic produced by the strain of Str. sannanensis sp. nov. It has weak antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.

It is an aminoglycoside antibiotic produced by the strain of Str. sannanensis sp. nov. It has weak antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.

It is a phenazine antibiotic produced by the strain of Str. canarius MG 314-hF8. It has strong effect against gram-positive bacteria and mycobacterium. It inhibits mouse leukemia L5178Y and L1210 cells with ID50 (μg/mL) of 0.15 and 0.6-2.5, respectively (in vitro determination).

It is produced by the strain of Str. sp. DO-116. It has anti-gram-positive bacteria effect. In vivo, it has the effect of anti-leukemia P388 and sarcoma 180 cells. Determination in vitro, it has the effect of causing single strand breaks in superhelical plasmid DNA.

It is produced by the strain of Str. nodosus MH190-16F3. It has antimicrobial effect, but it has weaker effect against gram-negative bacteria. It has inhibitory effect on leukemia P388 cells and adriamycin-resistant P388 cells.

It is produced by the strain of Str. nodosus MH190-16F3. It has antimicrobial effect, but it has weaker effect against gram-negative bacteria. It has inhibitory effect on leukemia P388 cells and adriamycin-resistant P388 cells.

It is produced by the strain of Str. nodosus MH190-16F3. It has antimicrobial effect, but it has weaker effect against gram-negative bacteria. It has inhibitory effect on leukemia P388 cells and adriamycin-resistant P388 cells.

It is produced by the strain of Str. nodosus MH190-16F3. It has antimicrobial effect, but it has weaker effect against gram-negative bacteria. It has inhibitory effect on leukemia P388 cells and adriamycin-resistant P388 cells.

It is produced by the strain of Str. nodosus MH190-16F3. It has antimicrobial effect, but it has weaker effect against gram-negative bacteria. It has inhibitory effect on leukemia P388 cells and adriamycin-resistant P388 cells.